Skip to content

Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City

Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04365530
Acronym
COVIDGHPSJCite
Enrollment
3767
Registered
2020-04-28
Start date
2020-04-01
Completion date
2023-03-06
Last updated
2023-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID

Brief summary

The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infection are elderly patients (\> 70 years), obese patients, patients with chronic renal or respiratory pathologies, cardiovascular history (stroke or coronary artery disease), chronic respiratory conditions, high blood pressure, diabetes, and cancer. Covid-19 is manifested by a risk of acute respiratory distress syndrome requiring management by invasive ventilation. The lethality of this infection is around 4% in the current data. Drastic precautionary measures for the transmission of the virus, as well as the provision of critical care beds by canceling any scheduled non-urgent intervention or consultation, have shaken up the hospital organization. In this context, it is essential to have forward-looking data in real time to adjust the care offer and better understand the impact of Covid-19 on the patient populations treated.

Interventions

None listed

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.

Exclusion criteria

* Asymptomatic patient * Patient objecting to the use of their data

Design outcomes

Primary

MeasureTime frameDescription
Clinical consequences of a Covid-19 infection in the care populationYear 2This outcome measures the clinical consequences of a Covid-19 infection in the care population.

Secondary

MeasureTime frameDescription
Risk factors at year 1Year 1This outcome evaluates the risk factors of COVID-19.
Risk factors at year 2Year 2This outcome evaluates the risk factors of COVID-19.
Risk factors at M6Month 6This outcome evaluates the risk factors of COVID-19 at month 6
Impact of hospital reorganization on medical care at Year 1Year 1This outcome evaluates the impact of hospital reorganization on medical care at year 1.
Impact of hospital reorganization on medical care at Year 2Year 2This outcome evaluates the impact of hospital reorganization on medical care at year 2.
Impact of hospital reorganization on medical care at M6Month 6This outcome evaluates the impact of hospital reorganization on medical care at month 6.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026